This inventor holds 8 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Regeneron Pharmaceuticals, Inc., Other. Active years: 2007-2025.
Company Filing History:
7 out of 1,471 
1 out of 834,307 Years Active: 2007-2025
Title: Scott Mellis: Innovator in Medical Treatments
Introduction
Scott Mellis is a notable inventor based in New Rochelle, NY (US). He has made significant contributions to the field of medical treatments, holding a total of 8 patents. His work primarily focuses on innovative methods for treating various medical conditions.
Latest Patents
Among his latest patents is a groundbreaking treatment for fibrodysplasia ossificans progressiva (FOP). This patent details methods for administering an anti-activin A antibody to effectively treat individuals suffering from this rare condition. Another significant patent involves the use of interleukin 1 (IL-1) antagonists to treat autoinflammatory diseases. This method provides therapeutic solutions for conditions such as Neonatal Onset Multisystem Inflammatory Disorder (NOMID/CINCA) and Muckle-Wells Syndrome (MWS), among others.
Career Highlights
Scott Mellis has worked with prominent companies in the pharmaceutical industry, including Regeneron Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to medical treatments.
Collaborations
Throughout his career, Scott has collaborated with talented individuals such as Joanne Papadopoulos and Margaret Karow. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Scott Mellis is a distinguished inventor whose work in medical treatments has the potential to improve the lives of many individuals. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.